Mishima, Japan

Yutaka Okada

This inventor holds 2 USPTO granted patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2009-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Okada. Retrieved from https://idiyas.com/inventor/yutaka-okada-0640wt3m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2009-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yutaka Okada: Innovator in Medicinal Chemistry

Introduction

Yutaka Okada is a prominent inventor based in Mishima-gun, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on carboxylic acid compounds.

Latest Patents

Yutaka Okada holds 2 patents that focus on carboxylic acid compounds and their medicinal applications. His latest patents include a compound represented by formula (I), which is designed to serve as an active ingredient in medicinal compositions.

Career Highlights

Okada is currently employed at Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has been instrumental in creating new therapeutic options for various medical conditions.

Collaborations

Throughout his career, Yutaka Okada has collaborated with notable colleagues, including Atsushi Naganawa and Maki Iwahashi. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yutaka Okada's contributions to medicinal chemistry and his innovative patents underscore his role as a key figure in the pharmaceutical industry. His ongoing work promises to lead to further advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…